Skip to content
ppharmaranks
Menu

dartisla odt

Pharmaranks rates Dartisla ODT 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Dartisla ODT (Glycopyrrolate) is an anticholinergic used to treat Hyperhidrosis, Drug-Induced Abnormalities, Peptic Ulcer, Respiratory Tract Diseases.

Glycopyrrolate · by Edenbridge Pharms

Available as a generic: Glycopyrrolate

70/100Limited · 1 source

Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass

Key facts

Active ingredient
Glycopyrrolate
Drug class
Anticholinergic
Form
Tablet, orally disintegrating
Strength
Glycopyrrolate 0.85MG · Glycopyrrolate 1.7MG
Type
Prescription (Rx)
Brand or generic
Brand-name
Manufacturer
Edenbridge Pharms
What the pharmacy pays
~$0.20 per ml — not your price
FDA application
NDA215019
Availability
Discontinued (per FDA)

Drug class

How this class works, per Muscarinic Antagonists - StatPearls - NCBI Bookshelf.

May treat (source: NIH RxClass)

See how Dartisla ODT ranks — best-rated anticholinergic for:

Dosage forms

Tablet, orally disintegrating

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Dartisla ODT treat?
Dartisla ODT (Glycopyrrolate) may be used to treat hyperhidrosis, drug-induced abnormalities, peptic ulcer, respiratory tract diseases, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
How does Dartisla ODT work?
Dartisla ODT is a anticholinergic. Anticholinergic drugs block acetylcholine, the chemical messenger of the body's "rest and digest" nervous system, by occupying its muscarinic receptors. This eases muscle spasms, dries up secretions, relaxes the bladder and airways, and speeds the heart, depending on the tissue.
How is Dartisla ODT rated?
pharmaranks gives Dartisla ODT a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
How much does Dartisla ODT cost?
Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $0.20 per ml, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
Is there a coupon or discount for Dartisla ODT?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Dartisla ODT. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Dartisla ODT?
Dartisla ODT is marketed by Edenbridge Pharms. You can see Edenbridge Pharms's full profile, rating, and other products on pharmaranks.
Is Dartisla ODT a brand-name or generic drug?
Dartisla ODT is a brand-name product with the active ingredient Glycopyrrolate. Lower-cost generic equivalents containing Glycopyrrolate are available — ask your pharmacist.
Is Dartisla ODT available over the counter?
No. Dartisla ODT is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Dartisla ODT come in?
Dartisla ODT is currently marketed as tablet, orally disintegrating, per the FDA's National Drug Code Directory.
What class of drug is Dartisla ODT?
Dartisla ODT is classified as anticholinergic, cholinergic muscarinic antagonist, per the FDA's Established Pharmacologic Class.
Is Dartisla ODT FDA-registered?
Dartisla ODT is on record with the U.S. FDA under application number NDA215019. You can verify this on its official FDA label.
Has Dartisla ODT been recalled by the FDA?
Dartisla ODT has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
Is Dartisla ODT safe?
There's no single safe-or-not verdict. pharmaranks gives Dartisla ODT a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about GLYCOPYRROLATE

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 9,620 reports naming GLYCOPYRROLATE — the active ingredient in Dartisla ODT, and the FDA flagged 89% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • dyspnoea1,584 reports
  • asthma1,018 reports
  • cough945 reports
  • pneumonia865 reports
  • wheezing813 reports
  • malaise585 reports
  • chronic obstructive pulmonary disease566 reports
  • fatigue549 reports

Read these as a signal, not a rate. A report does not mean GLYCOPYRROLATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Dartisla ODT head-to-head

More anticholinergic drugs

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.

dartisla odt

70/100